Session Information
-
WCLC 2021
2021 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
All times listed are in Mountain Time MDT (UTC-6:00)
PL - Plenary
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
WS - Workshops
IS - Industry Symposium
MTE - Meet the Expert
BEDG - Brain Exchange Discussion Groups
September 8 Wed
Sep 8 Thursday
September 9 Thu
Sep 9 Friday
September 10 Fri
Sep 10 Saturday
September 11 Sat
Sep 11 Sunday
September 12 Sun
Sep 12 Monday
September 13 Mon
Sep 13 Tuesday
September 14 Tue
Sep 14
-
+
P27 - Locally Advanced Non-Small Cell Lung Cancer - Other & Local Treatment Toxicity
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Locally Advanced Non-Small Cell Lung Cancer
-
+
P27.01 - Patterns of Care and Outcomes in Clinical T3N0M0 Non-Small Cell Lung Cancer Without Invasion of Other Structures
00:00 - 00:00 | Presenter: Matthew Willis Parsons
- Abstract
Loading...
-
+
P63 - Small Cell Lung Cancer/ NET - Clinical Studies
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Small Cell Lung Cancer/ NET
-
+
P63.11 - Real-World Survival Outcomes of Patients with Limited Stage Small Cell Lung Cancer (LS-SCLC) by Choice of Platinum Chemotherapy
00:00 - 00:00 | Presenter: Shiven Bharat Patel
- Abstract
Loading...
-
+
MTE06 - Meet the Expert - Academic and Community Crossover - Increasing Interdisciplinary Collaboration
- 15:00 - 16:00
- 9/12/2021
- Location: IASLC Booth via Industry Hub and Exhibit Hall
- Not for CME Credit
- Type: Meet the Expert Sessions
- Track: N.A.
- Moderators:Sonam Puri
-
+
MTE06.01 - Academic and Community Crossover - Increasing Interdisciplinary Collaboration
15:00 - 16:00 | Presenter: Sarah B Goldberg
- Abstract
No abstract available for this presentation
-
+
MA13 - Building on the Past: What Will Be the Next Immunotherapy Combination?
- 17:30 - 18:30
- 9/13/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Mini Oral
- Track: Immunotherapy (Phase II/III Trials)
-
+
MA13.02 - Phase II Study of Nivolumab and Ipilimumab Combined With Nintedanib in Recurrent Non-Small Cell Lung Cancer
17:35 - 17:40 | Presenter: Sonam Puri
- Abstract
Loading...
-
+
ES12 - A Precision Approach to Stage III Non-small Cell Lung Cancer*
- 17:30 - 18:05
- 9/14/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Education Session
- Track: Locally Advanced Non-Small Cell Lung Cancer
*Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.- Moderators:Benjamin Besse, Jhanelle Gray
-
+
ES12.03 - Adjuvant and Neoadjuvant Approaches in Stage III Non-Small Cell Lung Cancer
17:34 - 17:36 | Presenter: Sonam Puri
- Abstract
No abstract available for this presentation